MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.7431
+0.0231 (3.21%)
At close: Aug 21, 2026, 4:00 PM EDT
0.723929
-0.0192 (-2.58%)
After-hours: Aug 21, 2026, 7:49 PM EDT
MDxHealth Revenue
MDxHealth had revenue of $27.21M in the quarter ending June 30, 2026, with 16.31% growth. This brings the company's revenue in the last twelve months to $84.36M, down -11.88% year-over-year. In the year 2025, MDxHealth had annual revenue of $107.88M with 19.80% growth.
Revenue (ttm)
$84.36M
Revenue Growth
-11.88%
P/S Ratio
0.62
Revenue / Employee
$313,253
Employees
364
Market Cap
70.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 107.88M | 17.83M | 19.80% |
| Dec 31, 2024 | 90.05M | 19.86M | 28.29% |
| Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
| Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
| Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
| Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
| Dec 31, 2019 | 11.79M | -16.61M | -58.50% |
| Dec 31, 2018 | 28.40M | -12.11M | -29.90% |
| Dec 31, 2017 | 40.51M | 10.54M | 35.16% |
| Dec 31, 2016 | 29.97M | 12.33M | 69.90% |
| Dec 31, 2015 | 17.64M | 5.97M | 51.14% |
| Dec 31, 2014 | 11.67M | 4.12M | 54.50% |
| Dec 31, 2013 | 7.55M | 1.64M | 27.75% |
| Dec 31, 2012 | 5.91M | 2.17M | 58.10% |
| Dec 31, 2011 | 3.74M | 349.41K | 10.31% |
| Dec 31, 2010 | 3.39M | -262.90K | -7.20% |
| Dec 31, 2009 | 3.65M | -560.84K | -13.31% |
| Dec 31, 2008 | 4.21M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | 3.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 806.60M |
| Fulgent Genetics | 323.93M |
| Biodesix | 102.94M |
| Burning Rock Biotech | 74.58M |
| Exagen | 71.12M |
| XWELL | 28.28M |
| Precipio | 27.20M |
| Insight Molecular Diagnostics | 1.67M |
MDXH News
- 1 day ago - MDxHealth price target lowered to $2 from $4 at BTIG - TheFly
- 5 days ago - MDxHealth reports Q2 EPS (18c) vs. (14c) last year - TheFly
- 5 days ago - MDxHealth price target lowered to $3 from $5 at Lake Street - TheFly
- 8 days ago - MDxHealth Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - MDxHealth Earnings release: Q2 2026 - Filings
- 8 days ago - Mdxhealth Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 9 days ago - MDxHealth Slides: Corporate presentation - Filings
- 22 days ago - Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 - GlobeNewsWire